Cancer by Sfakianakis Alexandros: Should decisions on adding adjuvant chemotherapy in early stage ER positive breast cancer be based on gene expression testing or clinicopathologic factors or both?

Τρίτη 3 Απριλίου 2018

Should decisions on adding adjuvant chemotherapy in early stage ER positive breast cancer be based on gene expression testing or clinicopathologic factors or both?

from Cancer via ola Kala on Inoreader https://ift.tt/2q5nAOR
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)